Association study of transition of laboratory marker levels and transition of disease activity of atopic dermatitis patients treated with dupilumab.

Maki MizunoGo HoriguchiSatoshi TeramukaiSusumu IchiyamaMichiko ItoToshihiko HoashiNaoko Kanda Hidehisa Saeki

Published in: The Australasian journal of dermatology (2021)

Laboratory markers are useful for evaluating the effects of treatments for AD, but the meaning of each laboratory marker depends on the drugs used for treatment.

Keyphrases

atopic dermatitis
disease activity
rheumatoid arthritis
systemic lupus erythematosus
rheumatoid arthritis patients
ankylosing spondylitis
juvenile idiopathic arthritis
palliative care
combination therapy
advanced cancer